The effect of ALPN on gene expression in skin biopsies from volunteers with psoriasis.

Completed

• Conditions: psoriasis; 10014982

• Registration Number: NL-OMON45844
• Lead Sponsor: Derphartox

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 8

Inclusion Criteria

Patients with moderate to severe psoriasis

Exclusion Criteria

Volunteers undergoing UV/light therapy or taking systemic drugs such as cyclosporin A or methotrexate Volunteers using local topical corticosteroids
Volunteers developing Köbner phenomenon at wound sites

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Effect of ALPN test compounds on gene expression in psoriasis.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>